Tracing the taxonomic journey of ostracods: from Linnaeus to Latreille, through Micheli-Targioni Tozzetti’s collections
2024-01-01 Mazzini, Ilaria; Cianfanelli, Simone; Lori, Elisabetta; Rossetti, Giampaolo; Innocenti, Gianna; Talenti, Enrico
Littoral living Ostracoda from the Bracciano caldera-lake (Sabatini volcanic complex, central Italy)
2024-01-01 Gliozzi, Elsa; Rossetti, Giampaolo; Mazzini, Ilaria; Ceschin, Simona; Argenti, Emmanuelle; Faranda, Costanza; Cantadori, Nicholas; DI LORETO, Matteo
Vision and learning in non-marine ostracods
2024-01-01 Bellavere, Elena; MATZKE-KARASZ, Renate; Romano, Donato; Rossetti, Giampaolo
Visual and cognitive abilities of non-marine ostracods in a colorful world
2024-01-01 Bellavere, Elena; Rossetti, Giampaolo; MESQUITA-JOANES, Francesc; Romano, Donato
Sex-based variability in cardiac electromechanical properties: Insights into arrhythmia susceptibility and protection
2024-01-01 Rossi, S.; Statello, R.; Muzio, F. P. L.; Pela, G.; Cabassi, A.; Macchi, E.; Miragoli, M.
Video analysis of ex-vivo beating hearts during preservation on the TransMedics® organ care system
2024-01-01 Berrettoni, S.; Pla, M. M.; Lee, F. H.; Rozzi, G.; Gross, R. T.; Evans, A.; Wendell, D. C.; Lezberg, P.; Burattini, M.; Muzio, F. P. L.; Fassina, L.; Milano, C. A.; Bang, M. -L.; Bowles, D. E.; Miragoli, M.
MELAS syndrome: Insights into cardiac mechanics
2024-01-01 Burattini, M.; Pisano, A.; Medeghini, V.; Rossi, S.; Luciani, G. B.; D'Amati, G.; Miragoli, M.
Efficacy-toxicity relationship analysis of cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy (CT): Interim results from the phase 2 ARCADIA trial.
2023-01-01 Vela, C.; Rollo, L.; Bottiglieri, A.; Malena, G.; Guadalupi, V.; Marandino, L.; Raggi, D.; Stellato, M.; Rametta, A.; Sepe, P.; Claps, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Verzoni, E.; Procopio, G.; Necchi, A.; Giannatempo, P.
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors.
2023-01-01 Buti, S.; Pecci, F.; Maffezzoli, M.; Giudice, G. C.; Cognigni, V.; Mazzaschi, G.; Cantini, L.; Santamaria, L.; Paoloni, F.; Berardi, R.; Perrone, F.
Potential ROle of hypovitaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): a prospective observational study.
2023-01-01 Giudice, G. C.; Cortellini, A.; Leonetti, A.; Parisi, A.; Tiseo, M.; Bordi, P.; Michiara, M.; Bui, S.; Cosenza, A.; Ferri, L.; Testi, I.; Vincenzi, B.; Santo, V.; Ricozzi, V.; Sgargi, P.; Zustovich, F.; Stucci, L. S.; Santini, D.; Buti, S.; Bersanelli, M.
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling
2023-01-01 Mazzaschi, G.; Cardinale, E.; Pluchino, M.; Monica, G.; Lorusso, B.; D’Agnelli, S.; Trentini, F.; Tamarozzi, P.; Moron Dalla Tor, L.; Verzè, M.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Buti, S.; Cosenza, A.; Quaini, F.; Sverzellati, N.; Tiseo, M.
Clinical relevance of first-line tyrosine kinase inhibitor (TKI) choice in metastatic renal cell carcinoma (mRCC) patients (pts) receiving second-line nivolumab (Meet-URO 15 study).
2023-01-01 Catalano, F.; Signori, A.; Sorarù, M.; Malgeri, A.; Di Napoli, M.; Caffo, O.; Vignani, F.; Cavo, A.; Roviello, G.; Prati, V.; Tudini, M.; Atzori, F.; Messina, M.; Damassi, A.; Morelli, F.; Prati, G.; Nolè, F.; Rescigno, P.; Buti, S.; Rebuzzi, S. E.
Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)
2023-01-01 D’Agostino, E.; Baldessari, C.; Farioli, F.; Agresti, G.; Basso, U.; Buti, S.; Favaretto, A.; Pettorelli, E.; Bacchelli, F.; Oltrecolli, M.; Pirola, M.; Roccabruna, S.; Pugliese, G.; Pipitone, S.; Vitale, M. G.; Fiocchi, F.; Dominici, M.; Sabbatini, R.
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study.
2023-01-01 Maffezzoli, M.; Fiala, O.; Buti, S.; Massari, F.; Iacovelli, R.; Martignetti, A.; Morelli, F.; Mollica, V.; Porta, C.; Rizzo, M.; Rizzo, A.; Incorvaia, L.; Ciccarese, C.; Santoni, M.
Geographical differences in the management of metastatic de novo Renal Cell Carcinoma in the era of immune-combinations with a focus on the role of cytoreductive nephrectomy: an analysis from ARON- 1 Project.
2023-01-01 Rizzo, M.; Mollica, V.; Incorvaia, L.; Galli, L.; Merler, S.; Iacovelli, R.; Chiari, R.; Zucali, P. A.; Scagliarini, S.; De Giorgi, U.; Berardi, R.; Procopio, G.; Atzori, F.; Buti, S.; Bamias, A.; Battelli, N.; Grande, E.; Porta, C.; Massari, F.; Santoni, M.
Time to treatment failure (TTF) and treatment beyond progression (TBP) as survival outcome and therapeutic strategy of clinical benefit in pretreated metastatic renal cell carcinoma (mRCC) patients receiving nivolumab: a subanalysis of Meet-URO 15 study.
2023-01-01 Murianni, V.; Signori, A.; Buti, S.; Maruzzo, M.; De Giorgi, U.; Zucali, P. A.; Procopio, G.; Fratino, L.; Pipitone, S.; Mollica, V.; Lombardo, V.; Chiellino, S.; Galli, L.; Masini, C.; Naglieri, E.; Milella, M.; Ricotta, R.; Banna, G. L.; Cremante, M.; Rebuzzi, S. E.
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study
2023-01-01 Rebuzzi, S. E.; Brunelli, M.; Signori, A.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Galli, L.; Spada, M.; Milella, M.; Masini, C.; Cavo, A.; Vignani, F.; Catalano, F.; Maffezzoli, M.; Rescigno, P.; Banna, G. L.; Basso, U.; Buti, S.; Fornarini, G.
Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC). The Tide-A study
2023-01-01 Iacovelli, R.; Ciccarese, C.; Bersanelli, M.; Zucali, P. A.; Fantinel, E.; Bimbatti, D.; Verzoni, E.; Accettura, C.; Bonomi, L.; Buttigliero, C.; Fornarini, G.; Pipitone, S.; Atzori, F.; Masini, C.; Massari, F.; Primi, F.; Buti, S.; Perrino, M.; Pafumi, S.; Tortora, G.
Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC)
2024-01-01 Bracarda, Sergio; Antonuzzo, Lorenzo; Maruzzo, Marco; Santini, Daniele; Tambaro, Rosa; Buti, Sebastiano; Carrozza, Francesco; Calabrò, Fabio; Di Lorenzo, Giuseppe; Fornarini, Giuseppe; Iacovelli, Roberto; Cullurà, Daniela; Messina, Carlo; Cerbone, Linda; Fazzi, Gennaro; Venturini, Filippo; Colasanto, Raffaele; Necchi, Andrea; De Giorgi, Ugo
International multicenter real-world registry for patients with metastatic renal cell carcinoma: Meet-URO 33 study (REGAL study)
2024-01-01 Rebuzzi, Sara Elena; Fornarini, Giuseppe; Signori, Alessio; Buti, Sebastiano; Procopio, Giuseppe; De Giorgi, Ugo; Pignata, Sandro; Naglieri, Emanuele; Maruzzo, Marco; Banna, Giuseppe Luigi; Rescigno, Pasquale; Messina, Carlo; Nasso, Cecilia; Murianni, Veronica; Cremante, Malvina; Damassi, Alessandra; Catalano, Fabio; Mattana, Alvise; Basso, Umberto; Bimbatti, Davide; Null, Null
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Tracing the taxonomic journey of ostracods: from Linnaeus to Latreille, through Micheli-Targioni Tozzetti’s collections | 1-gen-2024 | Mazzini, Ilaria; Cianfanelli, Simone; Lori, Elisabetta; Rossetti, Giampaolo; Innocenti, Gianna; Talenti, Enrico | |
Littoral living Ostracoda from the Bracciano caldera-lake (Sabatini volcanic complex, central Italy) | 1-gen-2024 | Gliozzi, Elsa; Rossetti, Giampaolo; Mazzini, Ilaria; Ceschin, Simona; Argenti, Emmanuelle; Faranda, Costanza; Cantadori, Nicholas; DI LORETO, Matteo | |
Vision and learning in non-marine ostracods | 1-gen-2024 | Bellavere, Elena; MATZKE-KARASZ, Renate; Romano, Donato; Rossetti, Giampaolo | |
Visual and cognitive abilities of non-marine ostracods in a colorful world | 1-gen-2024 | Bellavere, Elena; Rossetti, Giampaolo; MESQUITA-JOANES, Francesc; Romano, Donato | |
Sex-based variability in cardiac electromechanical properties: Insights into arrhythmia susceptibility and protection | 1-gen-2024 | Rossi, S.; Statello, R.; Muzio, F. P. L.; Pela, G.; Cabassi, A.; Macchi, E.; Miragoli, M. | |
Video analysis of ex-vivo beating hearts during preservation on the TransMedics® organ care system | 1-gen-2024 | Berrettoni, S.; Pla, M. M.; Lee, F. H.; Rozzi, G.; Gross, R. T.; Evans, A.; Wendell, D. C.; Lezberg, P.; Burattini, M.; Muzio, F. P. L.; Fassina, L.; Milano, C. A.; Bang, M. -L.; Bowles, D. E.; Miragoli, M. | |
MELAS syndrome: Insights into cardiac mechanics | 1-gen-2024 | Burattini, M.; Pisano, A.; Medeghini, V.; Rossi, S.; Luciani, G. B.; D'Amati, G.; Miragoli, M. | |
Efficacy-toxicity relationship analysis of cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy (CT): Interim results from the phase 2 ARCADIA trial. | 1-gen-2023 | Vela, C.; Rollo, L.; Bottiglieri, A.; Malena, G.; Guadalupi, V.; Marandino, L.; Raggi, D.; Stellato, M.; Rametta, A.; Sepe, P.; Claps, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Verzoni, E.; Procopio, G.; Necchi, A.; Giannatempo, P. | |
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. | 1-gen-2023 | Buti, S.; Pecci, F.; Maffezzoli, M.; Giudice, G. C.; Cognigni, V.; Mazzaschi, G.; Cantini, L.; Santamaria, L.; Paoloni, F.; Berardi, R.; Perrone, F. | |
Potential ROle of hypovitaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): a prospective observational study. | 1-gen-2023 | Giudice, G. C.; Cortellini, A.; Leonetti, A.; Parisi, A.; Tiseo, M.; Bordi, P.; Michiara, M.; Bui, S.; Cosenza, A.; Ferri, L.; Testi, I.; Vincenzi, B.; Santo, V.; Ricozzi, V.; Sgargi, P.; Zustovich, F.; Stucci, L. S.; Santini, D.; Buti, S.; Bersanelli, M. | |
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling | 1-gen-2023 | Mazzaschi, G.; Cardinale, E.; Pluchino, M.; Monica, G.; Lorusso, B.; D’Agnelli, S.; Trentini, F.; Tamarozzi, P.; Moron Dalla Tor, L.; Verzè, M.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Buti, S.; Cosenza, A.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
Clinical relevance of first-line tyrosine kinase inhibitor (TKI) choice in metastatic renal cell carcinoma (mRCC) patients (pts) receiving second-line nivolumab (Meet-URO 15 study). | 1-gen-2023 | Catalano, F.; Signori, A.; Sorarù, M.; Malgeri, A.; Di Napoli, M.; Caffo, O.; Vignani, F.; Cavo, A.; Roviello, G.; Prati, V.; Tudini, M.; Atzori, F.; Messina, M.; Damassi, A.; Morelli, F.; Prati, G.; Nolè, F.; Rescigno, P.; Buti, S.; Rebuzzi, S. E. | |
Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT) | 1-gen-2023 | D’Agostino, E.; Baldessari, C.; Farioli, F.; Agresti, G.; Basso, U.; Buti, S.; Favaretto, A.; Pettorelli, E.; Bacchelli, F.; Oltrecolli, M.; Pirola, M.; Roccabruna, S.; Pugliese, G.; Pipitone, S.; Vitale, M. G.; Fiocchi, F.; Dominici, M.; Sabbatini, R. | |
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study. | 1-gen-2023 | Maffezzoli, M.; Fiala, O.; Buti, S.; Massari, F.; Iacovelli, R.; Martignetti, A.; Morelli, F.; Mollica, V.; Porta, C.; Rizzo, M.; Rizzo, A.; Incorvaia, L.; Ciccarese, C.; Santoni, M. | |
Geographical differences in the management of metastatic de novo Renal Cell Carcinoma in the era of immune-combinations with a focus on the role of cytoreductive nephrectomy: an analysis from ARON- 1 Project. | 1-gen-2023 | Rizzo, M.; Mollica, V.; Incorvaia, L.; Galli, L.; Merler, S.; Iacovelli, R.; Chiari, R.; Zucali, P. A.; Scagliarini, S.; De Giorgi, U.; Berardi, R.; Procopio, G.; Atzori, F.; Buti, S.; Bamias, A.; Battelli, N.; Grande, E.; Porta, C.; Massari, F.; Santoni, M. | |
Time to treatment failure (TTF) and treatment beyond progression (TBP) as survival outcome and therapeutic strategy of clinical benefit in pretreated metastatic renal cell carcinoma (mRCC) patients receiving nivolumab: a subanalysis of Meet-URO 15 study. | 1-gen-2023 | Murianni, V.; Signori, A.; Buti, S.; Maruzzo, M.; De Giorgi, U.; Zucali, P. A.; Procopio, G.; Fratino, L.; Pipitone, S.; Mollica, V.; Lombardo, V.; Chiellino, S.; Galli, L.; Masini, C.; Naglieri, E.; Milella, M.; Ricotta, R.; Banna, G. L.; Cremante, M.; Rebuzzi, S. E. | |
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study | 1-gen-2023 | Rebuzzi, S. E.; Brunelli, M.; Signori, A.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Galli, L.; Spada, M.; Milella, M.; Masini, C.; Cavo, A.; Vignani, F.; Catalano, F.; Maffezzoli, M.; Rescigno, P.; Banna, G. L.; Basso, U.; Buti, S.; Fornarini, G. | |
Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC). The Tide-A study | 1-gen-2023 | Iacovelli, R.; Ciccarese, C.; Bersanelli, M.; Zucali, P. A.; Fantinel, E.; Bimbatti, D.; Verzoni, E.; Accettura, C.; Bonomi, L.; Buttigliero, C.; Fornarini, G.; Pipitone, S.; Atzori, F.; Masini, C.; Massari, F.; Primi, F.; Buti, S.; Perrino, M.; Pafumi, S.; Tortora, G. | |
Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) | 1-gen-2024 | Bracarda, Sergio; Antonuzzo, Lorenzo; Maruzzo, Marco; Santini, Daniele; Tambaro, Rosa; Buti, Sebastiano; Carrozza, Francesco; Calabrò, Fabio; Di Lorenzo, Giuseppe; Fornarini, Giuseppe; Iacovelli, Roberto; Cullurà, Daniela; Messina, Carlo; Cerbone, Linda; Fazzi, Gennaro; Venturini, Filippo; Colasanto, Raffaele; Necchi, Andrea; De Giorgi, Ugo | |
International multicenter real-world registry for patients with metastatic renal cell carcinoma: Meet-URO 33 study (REGAL study) | 1-gen-2024 | Rebuzzi, Sara Elena; Fornarini, Giuseppe; Signori, Alessio; Buti, Sebastiano; Procopio, Giuseppe; De Giorgi, Ugo; Pignata, Sandro; Naglieri, Emanuele; Maruzzo, Marco; Banna, Giuseppe Luigi; Rescigno, Pasquale; Messina, Carlo; Nasso, Cecilia; Murianni, Veronica; Cremante, Malvina; Damassi, Alessandra; Catalano, Fabio; Mattana, Alvise; Basso, Umberto; Bimbatti, Davide; Null, Null |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista1690
Data di pubblicazione
- 2020 - 2024150
- 2010 - 2019802
- 2000 - 2009512
- 1990 - 1999174
- 1980 - 198951
- 1979 - 19791
Editore
- ELSEVIER18
- SAGE PUBLICATIONS LTD15
- ASCO pubs11
- Elsevier7
- ASCO5
- ELSEVIER SCIENCE INC5
- TIPOGRAFIA PUBLISTAMPA S.N.C.4
- Edra3
- INT UNION CRYSTALLOGRAPHY3
- LIPPINCOTT WILLIAMS & WILKINS3
Rivista
- DIGESTIVE AND LIVER DISEASE101
- GASTROENTEROLOGY100
- BLOOD89
- ANNALS OF ONCOLOGY84
- HAEMATOLOGICA56
- JOURNAL OF CLINICAL ONCOLOGY56
- NEUROLOGICAL SCIENCES46
- UNITED EUROPEAN GASTROENTEROLOGY ...46
- ANNALS OF THE RHEUMATIC DISEASES30
- REUMATISMO26
Keyword
- Helicobacter pylori10
- sclerosi sistemica6
- Bioengineering5
- Gastroenterology5
- HCV5
- UV5
- GERD4
- anodal stimulation3
- beat-to-beat variability of cardi...3
- capillaroscopia3
Lingua
- eng879
- ita160
- fre1
Accesso al fulltext
- no fulltext1658
- reserved26
- open6